Ionia native Caitlin Cusack releases single after life-changing events
Cusacks debut single is available on all streaming platforms, including Spotify, Apple Music, Amazon Music, Tidal, Deezer and YouTube Music.
Source: sentinel-standard.com
📰 Multiple System Atrophy News
Page 23 - Multiple System Atrophy News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Multiple System Atrophy. Real-time updates on events, politics, business and more.
AskBio CEO and Co-Founder Sheila Mikhail receives 2022 Entrepreneurial Award from University of Chicago Booth School of Business
Prestigious recognition for outstanding professional achievement in the formation of a successful enterprise awarded to Booth School of Business A...
Northwestern University United States University Of Chicago North Carolina United Kingdom Research Triangle Park
Source: businessinsider.com
Alterity Therapeutics Launches ATH434 Phase 2 Clinical Trial for the Treatment of Patients with Multiple System Atrophy
Multiple System Atrophy is a rare, rapidly progressive, neurodegenerative disease that causes profound disabilityMELBOURNE, Australia, June 2, 202...
Source: businessinsider.com
Inhibikase Therapeutics Reports First Quarter 2022 Financial Results and Highlights Recent Period Activity
/PRNewswire/ -- Inhibikase Therapeutics, Inc. (Nasdaq: IKT) (Inhibikase or Company), a clinical-stage pharmaceutical company developing therapeutics to modify...
Source: prnewswire.com
Inhibikase Therapeutics Reports First Quarter 2022 Financial Results and Highlights Recent Period Activity
Company to host conference call and webcast on Tuesday, May 17, 2022, at 8:00am ETBOSTON and ATLANTA, May 16, 2022 /PRNewswire/ -- Inhibikase Ther...
Source: businessinsider.com
Amprion Awarded NIH Grant For Analytical Validation of SYNTap® Biomarker Test For Neurological Disease
San Francisco, CA (PRWEB) May 10, 2022 -- Amprion announces the National Institute of Neurological Disorders and Stroke (NINDS) has awarded an additional
San Diego United States Russ Lebovitz Claudio Soto Luis Concha National Institute Of Neurological Disorders
Source: prweb.com
Inhibikase Therapeutics to Participate at the H.C. Wainwright Global Investment Conference
/PRNewswire/ -- Inhibikase Therapeutics, Inc. (Nasdaq: IKT) (Inhibikase), a clinical-stage pharmaceutical company developing therapeutics to modify the course...
Source: prnewswire.com
Inhibikase Therapeutics to Report First Quarter 2022 Financial Results on May 16, 2022
/PRNewswire/ -- Inhibikase Therapeutics, Inc. (Nasdaq: IKT) (Inhibikase), a clinical-stage pharmaceutical company developing therapeutics to modify the course...
Source: prnewswire.com
Alterity receives MHRA authorisation for Phase II trial of MSA therapy
Alterity Therapeutics has received the MHRA acceptance for its request to proceed with Phase II trial of ATH434 in MSA.
United States New Zealand United Kingdom David Stamler Electronic Data Capture Solutions For Clinical Trials European Commission
Source: clinicaltrialsarena.com
Alterity Therapeutics Announces Regulatory Authorization to Proceed with ATH434 Phase 2 Clinical Trial in the United Kingdom
/PRNewswire/ -- Alterity Therapeutics (ASX: ATH, NASDAQ: ATHE) ("Alterity" or "the Company"), a biotechnology company dedicated to developing disease modifying...
Source: prnewswire.com